Aug 26 2021 |
The Application of “Authentication by Comparison” at the PTAB |
McDermott Will & Emery |
Jul 15 2013 |
The Architecture of Copyright |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 26 2020 |
The Art of An SEP War: A Chinese IP Court’s Recent Use of Anti-Suit Injunction Invites A Battle that It Likely Won’t Win |
Mintz |
Dec 7 2023 |
The Art of Teaching Complex Technology in Patent Litigation – Episode 67 [Podcast] |
IMS Legal Strategies |
Nov 28 2016 |
The Australian Patent Office Once Again Allows Claims Directed to Nucleic Acids |
K&L Gates |
Apr 28 2020 |
The Availability of Section 1782 Discovery in International Commercial Arbitration: A View from Northern California and the Epicenter of IP |
Squire Patton Boggs (US) LLP |
Aug 5 2020 |
The Balance Between Obviousness and Written Description — Lessons Learned from Recent Decisions |
Katten |
Dec 20 2023 |
The Barbie Movie: The Power of Brand Placement and Partnerships |
Foley & Lardner LLP |
Apr 8 2012 |
The Batching Games: ICANN’s Plan to Process New gTLD Applications |
Mintz |
Jan 8 2024 |
The Battle of the Bulls: NBA Fail to Invalidate Pizza Texas Bulls Trade Mark Similar to the Chicago Bulls Logo in the United Kingdom |
K&L Gates |
Dec 23 2022 |
THE BATTLE OF THE SUPERMARKETS VOL. 2 – Gingle Bells, Gingle Bells, Gin All the Way |
K&L Gates |
Dec 9 2022 |
The Battle of The Supermarkets – Evergreening of Trade Marks and Potential Bad Faith |
K&L Gates |
Sep 24 2021 |
The Battle over BLACK IRISH Liqueur |
Norris McLaughlin P.A. |
Jun 22 2023 |
The Best Option Is Obviously Not the Only Option |
McDermott Will & Emery |
Apr 11 2016 |
The Biggest Technology Give-Away in History? |
Schwegman, Lundberg & Woessner, P.A. |
Feb 2 2014 |
The Bill Graham Show Goes On … and On: Graham-Sult v. Clainos |
McDermott Will & Emery |
Jul 14 2020 |
The Bio/Pharma Beat July 2020 |
Squire Patton Boggs (US) LLP |
Mar 29 2023 |
The BioPharma Patent Cliff: 2023 and Beyond |
Foley & Lardner LLP |
Mar 13 2015 |
The Blurred Line Between Inspiration and Copying - A $7.4 Million Copyright Question |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 18 2017 |
The Board Gives Section 325(d) Sharp Teeth |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
Nov 15 2017 |
The Board Gives Section 325(d) Sharp Teeth—Part II – The Petitioner's Criticality to Selecting and Using The Right Prior Art |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
Dec 22 2017 |
The Board Gives Section 325(d) Sharp Teeth—Part III —Things Are Looking Up for Patent Owners |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
Sep 29 2022 |
The Board Is Back in Town: Arthrex Can’t Save Untimely Motions to Terminate |
McDermott Will & Emery |
Nov 6 2014 |
The Brazilian Patent Office Places the Fight against the Patent Application Backlog as its Top Priority |
Michael Best & Friedrich LLP |
Dec 8 2014 |
The Breadth of India’s “Bolar Exemption” |
Michael Best & Friedrich LLP |
Mar 31 2015 |
The Brinkmann Corporation v. A&J Manufacturing: Decision on Institution IPR2015-00056 |
Faegre Drinker |
Aug 20 2018 |
The CAFC Rules for Wider Application of Litigation Time Bar Against Filing of Inter Partes Reviews |
Barnes & Thornburg LLP |
Mar 15 2017 |
The CAFC Vacated the Northern District of California’s Claim Construction Because the District Court Improperly Limited the Claims Based on Prosecution History Disclaimer |
Hunton Andrews Kurth |
Apr 12 2018 |
The Carvedilol District Court Case: More May Be Needed to Prove Inducement from a Generic Product Label in the Context of an “At-Risk” Launch |
Brinks Gilson & Lione |
Apr 2 2021 |
The CASE Act: A Small Claims Court for Copyright Infringement |
Norris McLaughlin P.A. |
May 7 2014 |
The Case of Ophthalmic Drugs in Italy and France: A Lesson to Learn - Parallel Antitrust Investigations and Cooperation Between National Competition Authorities |
McDermott Will & Emery |
Jul 27 2021 |
The Case of the [Allegedly] Stolen & |
Finnegan |
Sep 22 2021 |
The Central Committee of the Communist Party of China and the State Council issued the “Guidelines for Building a Powerful Country with Intellectual Property Rights (2021-2035)” |
Schwegman, Lundberg & Woessner, P.A. |
Jun 27 2019 |
The Challenges of Patenting Autonomous Vehicle AI and Software |
Foley & Lardner LLP |
Oct 8 2017 |
The Cheerios Challenge of Registering Color Marks |
McDermott Will & Emery |
Jun 11 2020 |
The China National Intellectual Property Administration Aims to Speed Up Patent Prosecution |
Schwegman, Lundberg & Woessner, P.A. |
Jun 8 2020 |
The China National Intellectual Property Administration Announces Top 10 Patent Invalidation Cases of 2019 |
Schwegman, Lundberg & Woessner, P.A. |
Dec 16 2020 |
The China National Intellectual Property Administration Releases Guiding Cases for Administrative Enforcement of Intellectual Property Rights |
Schwegman, Lundberg & Woessner, P.A. |
Jan 15 2021 |
The China Pivot: Closing the “Back Door” to Trade Secret and IP Theft |
Sheppard, Mullin, Richter & Hampton LLP |
Jul 5 2018 |
The China Rules of Evidence Series – Online Purchase of Infringing Products and Forum Shopping in Trademark Infringement Cases |
Squire Patton Boggs (US) LLP |
May 22 2020 |
The Chinese Supreme People’s Court Intervenes on Patent Issues, with Focus on Pharmaceutical Experiments |
Squire Patton Boggs (US) LLP |
Aug 21 2019 |
The Claridge's Affair: A Win, but at What Cost? |
K&L Gates |
Feb 6 2024 |
The Cloudy World of Look-A-Like Products - Aldi Successfully Defends Allegations of Trade Mark Infringement |
K&L Gates |
Apr 13 2020 |
The Cold Hard Fact of Arctic Cat: Actual Notice is Necessary to Protect a Damages Claim from the Cold After Unmarked Patented Goods are Sold |
Squire Patton Boggs (US) LLP |
Oct 1 2015 |
The Complications of Copyrighted Images in the Yellow Pages |
McDermott Will & Emery |
Mar 6 2014 |
The Copaxone Story in the U.S. and India |
Michael Best & Friedrich LLP |
Apr 10 2014 |
The Copaxone Story in the U.S. and India: A Further Update |
Michael Best & Friedrich LLP |
Apr 4 2014 |
The Copaxone Story in the U.S. and India: An Update |
Michael Best & Friedrich LLP |
Apr 23 2014 |
The Copaxone Story in the U.S. and India: To Stay or Not to Stay is the Question |
Michael Best & Friedrich LLP |
Jan 22 2015 |
The Copaxone Story in the U.S. and India: U.S. Supreme Court Decision |
Michael Best & Friedrich LLP |